Enrollment Completed for Low-Risk Aortic and Mitral Patient Groups For On-X® Prosthetic Heart Valve Anticoagulation Clinical StudyMay 7, 2013 9:00 am | by The Associated Press | Comments
MINNEAPOLIS--(BUSINESS WIRE)--May 7, 2013--On-X ® Life Technologies, Inc. (On-X LTI) announced today that enrollment for the Low-Risk Aortic Valve and Mitral Valve Patient Groups has been completed. The Prospective Randomized On-X Valve Anticoagulation Trial (PROACT) was initiated with US FDA...
Changes in estrogen breakdown, or metabolism, may be one of the mechanisms by which aerobic exercise lowers a woman’s breast cancer risk, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
First Head-to-Head Study Shows GreenLight XPS Laser Therapy Equally Safe And Effective With Faster Recovery As Commonly Used TURP For Treatment Of BPHMay 6, 2013 4:02 pm | by PR Newswire | Comments
MINNETONKA, Minn., May 6, 2013 /PRNewswire/ -- Data to be presented tomorrow at the American Urological Association (AUA) Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia (BPH) with GreenLight XPS® laser therapy with MoXy® fiber, instead of...
KANSAS CITY, Mo., May 6, 2013 /PRNewswire/ -- Researchers from Children's Mercy Hospitals and Clinics in Kansas City, Mo., today presented data demonstrating that the Mercy TAPE, a new device to estimate the weight of pediatric patients (ages 2 months to 16 years old), is more...
Lung cancer is associated with very high mortality, in part because it is hard to detect at early stages, but also because it can recur frequently after surgical removal. The question arises as to what is the best way to follow lung cancer patients after surgery in order to spot problems early enough, before symptoms become obvious, so that patients may still be eligible for new interventions.
Electroconvulsive therapy is the most effective acute treatment for severe major depression. However, even with newer forms of ECT, there remains a significant risk of adverse cognitive effects, particularly memory problems. Current theories hold that the regions that need to be stimulated to treat the depression are different and separate from the regions that result in memory problems.
In a promising development for diabetes treatment, researchers have developed a network of nanoscale particles that can be injected into the body and release insulin when blood-sugar levels rise, maintaining normal blood sugar levels for more than a week in animal-based laboratory tests.
UCSF scientists controlled seizures in epileptic mice with a one-time transplantation of medial ganglionic eminence (MGE) cells, which inhibit signaling in overactive nerve circuits, into the hippocampus, a brain region associated with seizures, as well as with learning and memory.
Fully Automated Diagnostic Device Receives CE Certification; IDx LLC Planning For Rollout Across EuropeMay 6, 2013 10:26 am | by PR Newswire | Comments
IOWA CITY, Iowa, May 6, 2013 /PRNewswire/ -- IDx LLC, a company focused on deploying cutting-edge technology to make medical diagnostics more effective, announced earlier today that its first commercial product, IDx-DR, has received CE approval as a Class IIa medical device.
Double-amputee Jason Koger used to fly to visit a clinician when he wanted to adjust the grips on his bionic hands. Now, he's got an app instead. Koger this week demonstrated the i-limb ultra revolution, a prosthetic developed by the British firm Touch Bionics. Using a stylus and an iPhone, Koger can choose any of 24 grip patterns that best suit his needs.
HOUSTON, May 6, 2013 /PRNewswire/ -- Continuing to follow a remarkable path of innovation and growth, OrthoAccel® Technologies has announced the availability of their newest product, AcceleDent Aura, to orthodontic practices throughout the United States and Canada....
A handheld diagnostic device that Massachusetts General Hospital (MGH) investigators first developed to diagnose cancer has been adapted to rapidly diagnose tuberculosis (TB) and other important infectious bacteria. The portable devices combines microfluidic technology with nuclear magnetic resonance (NMR) to not only diagnose these important infections but also determine the presence of antibiotic-resistant bacterial strains.
Medtronic Announces FDA Approval of New Portfolio Of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-DefibrillatorsMay 6, 2013 10:18 am | by Medtronic | Comments
Medtronic, Inc. has announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of its newest cardiac devices: the Viva® portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices, and the Evera® portfolio of implantable cardioverter-defibrillators (ICD).
AATS Report: Prospective Randomized On-X Heart Valve Clinical Trial (PROACT) Provides Evidence of Reduced ComplicationsMay 6, 2013 9:00 am | by The Associated Press | Comments
MINNEAPOLIS--(BUSINESS WIRE)--May 6, 2013--On-X ® Life Technologies, Inc. (On-X LTI) announced today that interim results for the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT) are being presented at the American Association for Thoracic Surgery Annual (AATS) meeting by John...
AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core LabMay 6, 2013 9:00 am | by PR Newswire | Comments
BOSTON, May 6, 2013 /PRNewswire/ -- AG Mednet today announced a new core lab partnership with the Methodist DeBakey Heart & Vascular Center (MDHVC) echocardiography core laboratory at The Methodist Hospital in Houston. By selecting AG Mednet quality assurance and compliance...